Statins in pregnancy: new safety data are reassuring, but suspension of treatment is still advisable
BMJ
.
2015 Mar 17:350:h1484.
doi: 10.1136/bmj.h1484.
Authors
Françoise Haramburu
1
,
Amélie Daveluy
2
,
Ghada Miremont-Salamé
2
Affiliations
1
Bordeaux Regional Pharmacovigilance Centre, CHU de Bordeaux, France, INSERM U657, France francoise.haramburu@u-bordeaux.fr.
2
Bordeaux Regional Pharmacovigilance Centre, CHU de Bordeaux, France, INSERM U657, France.
PMID:
25784692
DOI:
10.1136/bmj.h1484
No abstract available
Publication types
Editorial
Comment
MeSH terms
Abnormalities, Drug-Induced / etiology*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Pregnancy
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors